84.63
前日終値:
$82.32
開ける:
$82.4
24時間の取引高:
340.71K
Relative Volume:
0.99
時価総額:
$1.93B
収益:
$883.37M
当期純損益:
$71.37M
株価収益率:
25.25
EPS:
3.3516
ネットキャッシュフロー:
$150.90M
1週間 パフォーマンス:
+7.81%
1か月 パフォーマンス:
+14.04%
6か月 パフォーマンス:
-8.63%
1年 パフォーマンス:
+16.63%
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
名前
Ani Pharmaceuticals Inc
セクター
電話
(218) 634-3500
住所
210 MAIN STREET WEST, BAUDETTE, MN
Compare ANIP vs TAK, ZTS, TEVA, HLN, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ANIP
Ani Pharmaceuticals Inc
|
84.63 | 1.87B | 883.37M | 71.37M | 150.90M | 3.3516 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.32B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
112.54 | 47.38B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.16B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
HLN
Haleon Plc Adr
|
9.17 | 41.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
UTHR
United Therapeutics Corp
|
572.20 | 24.67B | 3.18B | 1.33B | 1.04B | 27.90 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-10 | 開始されました | H.C. Wainwright | Buy |
| 2025-03-14 | 開始されました | Jefferies | Buy |
| 2025-03-12 | 開始されました | JP Morgan | Overweight |
| 2024-12-11 | 開始されました | Leerink Partners | Outperform |
| 2024-10-11 | 開始されました | Piper Sandler | Overweight |
| 2024-03-15 | 開始されました | CapitalOne | Overweight |
| 2023-08-22 | 繰り返されました | H.C. Wainwright | Buy |
| 2023-03-01 | 開始されました | Guggenheim | Buy |
| 2022-09-07 | 開始されました | H.C. Wainwright | Buy |
| 2021-11-02 | 開始されました | Truist | Buy |
| 2020-05-07 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | 開始されました | Guggenheim | Buy |
| 2019-05-10 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | 繰り返されました | Canaccord Genuity | Buy |
| 2017-07-31 | 開始されました | Canaccord Genuity | Buy |
| 2017-02-22 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2016-06-23 | 開始されました | Raymond James | Strong Buy |
| 2016-05-24 | ダウングレード | Standpoint Research | Buy → Hold |
| 2015-11-13 | 開始されました | Standpoint Research | Buy |
| 2015-09-28 | アップグレード | ROTH Capital | Neutral → Buy |
| 2015-08-05 | 繰り返されました | Oppenheimer | Outperform |
| 2015-08-04 | 繰り返されました | ROTH Capital | Neutral |
| 2015-07-31 | 繰り返されました | Oppenheimer | Outperform |
| 2015-07-15 | 繰り返されました | ROTH Capital | Neutral |
| 2015-06-23 | 繰り返されました | Oppenheimer | Outperform |
| 2015-05-18 | 繰り返されました | ROTH Capital | Neutral |
| 2015-05-06 | 繰り返されました | Oppenheimer | Outperform |
| 2015-04-10 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2015-02-26 | 繰り返されました | ROTH Capital | Buy |
| 2015-02-18 | 繰り返されました | Oppenheimer | Outperform |
すべてを表示
Ani Pharmaceuticals Inc (ANIP) 最新ニュース
MSN Money - MSN
Hussman Strategic Advisors Inc. Takes Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Artemis Investment Management LLP Invests $1.71 Million in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
ANI Pharmaceuticals (ANIP) Announces Launch of Pimozide Tablets 1 mg and 2 mg - Insider Monkey
ANI Pharmaceuticals (ANIP) Expected to Announce Earnings on Friday - MarketBeat
Zacks.com featured highlights include Mirion Technologies, Intuit and ANI Pharmaceuticals - Yahoo Finance
9 Best Drug Stocks to Buy According to Analysts - Insider Monkey
NTLA Falls 4% Despite Strong Phase III HAE Data, Initiates Rolling BLA - TradingView
ANI Pharmaceuticals rolls out generic carbamazepine extended-release capsules - MSN
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
What ANI Pharmaceuticals (ANIP)'s Niche CNS Generic Launches Mean For Its Specialty-First Strategy - Sahm
Assessing ANI Pharmaceuticals (ANIP) Valuation After New U.S. Generic Drug Launches - Yahoo Finance
Organon Shares Rally 16% in Premarket as Sun Pharma Announces Buyout - TradingView
ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET - marketscreener.com
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Passes Below 200-Day Moving AverageHere's Why - MarketBeat
Here's Why ANI Pharmaceuticals (ANIP) is a Strong Momentum Stock - Yahoo Finance
How Investors Are Reacting To ANI Pharmaceuticals (ANIP) New Generics Push And ILUVIEN Trial Data - Sahm
ANI Pharmaceuticals launches generic pimozide tablets By Investing.com - Investing.com India
ANI Pharmaceuticals' 2026 Catalysts Include Gout Push and New Generics - Yahoo Finance
Is ANIP Stock Undervalued at 10x Forward Earnings and $93 Target? - TradingView
ANIP's Cortrophin Gel Surge Powers 2026 Growth Outlook - Yahoo Finance
Here's Why ANI Pharmaceuticals (ANIP) is a Strong Growth Stock - Yahoo Finance
ANI Pharmaceuticals launches generic pimozide tablets - Investing.com
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity - The Manila Times
ANI Pharma (ANIP) Stock: Invest or Wait? (+3.65%) 2026-04-18Stop Loss Levels - Cổng thông tin điện tử tỉnh Lào Cai
ANI Pharmaceuticals (NASDAQ:ANIP) Upgraded by Zacks Research to Strong-Buy Rating - MarketBeat
Analysts Offer Insights on Healthcare Companies: Ceribell, Inc. (CBLL), ANI Pharmaceuticals (ANIP) and Amylyx Pharmaceuticals Inc (AMLX) - The Globe and Mail
ANI Pharmaceuticals News Highlights Undervalued Shares And New Specialty Generics - Sahm
Assessing ANI Pharmaceuticals (ANIP) Valuation After Recent Mixed Share Price Performance - Sahm
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
ANI Pharmaceuticals Launches Carbamazepine Extended-Release Capsules - Intellectia AI
ANI Pharmaceuticals launches generic carbamazepine capsules By Investing.com - Investing.com India
ANIP News | ANI PHARMACEUTICALS INC (NASDAQ:ANIP) - ChartMill
Ani Pharmaceuticals Inc (ANIP) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):